Terms: = Lung cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
1282 results:
1. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract] [Full Text] [Related]
2. Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.
Seckinger A; Buatois V; Moine V; Daubeuf B; Richard F; Chatel L; Viandier A; Bosson N; Rousset E; Masternak K; Salgado-Pires S; Batista C; Mougin C; Juan-Bégeot F; Poitevin Y; Hose D
Front Immunol; 2024; 15():1378813. PubMed ID: 38720892
[TBL] [Abstract] [Full Text] [Related]
3. [
Cegla P; Currie GM; Cholewinski W; Bryl M; Trojanowski M; Matuszewski K; Piotrowski T; Czepczyński R
Radiography (Lond); 2024 May; 30(3):971-977. PubMed ID: 38663216
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative nomogram for predicting spread through air spaces in clinical-stage IA non-small cell lung cancer using
Wang Y; Lyu D; Cheng C; Zhou T; Tu W; Xiao Y; Zuo C; Fan L; Liu S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):185. PubMed ID: 38598007
[TBL] [Abstract] [Full Text] [Related]
5. Development, synthesis and validation of improved c-Myc/max inhibitors.
Yıldırım S; Kocabaş F; Mermer A
J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
[TBL] [Abstract] [Full Text] [Related]
6. Standardized uptake value
Jin B; Wen X; Tian H; Guo H; Hao M; Wu J; Li X; Ren Y; Wang X; Ren X
Cancer Med; 2024 Apr; 13(7):e6961. PubMed ID: 38549459
[TBL] [Abstract] [Full Text] [Related]
7. Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell lung cancer.
Hashimoto K; Kaira K; Imai H; Miura YU; Shiono A; Mouri A; Yamaguchi OU; Kobayashi K; Kagamu H; Kuji I
Anticancer Res; 2024 Apr; 44(4):1541-1551. PubMed ID: 38537960
[TBL] [Abstract] [Full Text] [Related]
8. An
Thor M; Lee C; Sun L; Patel P; Apte A; Grkovski M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Chaft JE; Rimner A; Gomez DR; Deasy JO; Shaverdian N
J Nucl Med; 2024 Apr; 65(4):520-526. PubMed ID: 38485270
[TBL] [Abstract] [Full Text] [Related]
9. Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.
Malik H; Anees T
PLoS One; 2024; 19(3):e0296352. PubMed ID: 38470893
[TBL] [Abstract] [Full Text] [Related]
10.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract] [Full Text] [Related]
11. Promising Candidate Prognostic Biomarkers in [
Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
[TBL] [Abstract] [Full Text] [Related]
12. Amide proton transfer-weighted imaging and stretch-exponential model DWI based
Meng N; Song C; Sun J; Liu X; Shen L; Zhou Y; Dai B; Yu X; Wu Y; Yuan J; Yang Y; Wang Z; Wang M
Cancer Imaging; 2024 Mar; 24(1):33. PubMed ID: 38439101
[TBL] [Abstract] [Full Text] [Related]
13. Embedding machine learning based toxicity models within radiotherapy treatment plan optimization.
Maragno D; Buti G; Birbil Şİ; Liao Z; Bortfeld T; den Hertog D; Ajdari A
Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412530
[No Abstract] [Full Text] [Related]
14. [Correlation between prognostic nutritional index and pleural thickness with survival time of epithelial malignant pleural mesothelioma patients].
Zhou JH; Zhang YL; Li LF; Lu PL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Feb; 42(2):118-123. PubMed ID: 38403420
[No Abstract] [Full Text] [Related]
15. Prediction of Microwave Ablation Recurrence in Pulmonary Malignancies Using Preoperative Computed Tomography Radiomics Models.
Zhu F; Yang C; Yang J; Mao H; Huang Y; Liu H; Zhao Z
Curr Med Imaging; 2024; 20():1-26. PubMed ID: 38389378
[TBL] [Abstract] [Full Text] [Related]
16. Need for Objective Task-Based Evaluation of Image Segmentation Algorithms for Quantitative PET: A Study with ACRIN 6668/RTOG 0235 Multicenter Clinical Trial Data.
Liu Z; Mhlanga JC; Xia H; Siegel BA; Jha AK
J Nucl Med; 2024 Mar; 65(3):485-92. PubMed ID: 38360049
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
[TBL] [Abstract] [Full Text] [Related]
18. 18 F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18 F-FDG PET/CT for preoperative prediction: a new prognostication model.
Yang H; Liu X; Wang L; Zhou W; Tian Y; Dong Y; Zhou K; Chen L; Wang M; Wu H
Nucl Med Commun; 2024 Apr; 45(4):338-346. PubMed ID: 38312089
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of Individualized Silicone Rubber Bolus Using Fan Beam Computed Tomography in Postmastectomy Radiotherapy: A Dosimetric Evaluation and Skin Acute Radiation Dermatitis Survey.
Chen XM; Xu CD; Zeng LP; Huang XT; Chen AQ; Liu L; Lin LW; Jia LC; Li H; Jiang XB
Technol Cancer Res Treat; 2024; 23():15330338241229367. PubMed ID: 38297814
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study.
Bian Y; Ma S; Yao Q; Hu T; Ge M; Li H; Zheng S; Gu Z; Feng H; Yu Z; Huang C; Zhang H; Zhao L; Miao L
Expert Opin Investig Drugs; 2024 Jan; 33(1):63-72. PubMed ID: 38224050
[TBL] [Abstract] [Full Text] [Related]
[Next]
